Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: Higher incidence in patients with midventricular obstruction  by Fighali, Sayid et al.
288 lACC Vol. 9. No.2
February 1987:288-94
Progression of Hypertrophic Cardiomyopathy Into a Hypokinetic
Left Ventricle: Higher Incidence in Patients With
Midventricular Obstruction
SAYID FIGHALI, MD, ZVONIMIR KRAJCER, MD, FACC, SIDNEY EDELMAN, PHD,
ROBERT D. LEACHMAN, MD, FACC
Houston, Texas
The development of segmental or generalized left ven-
tricular hypokinesia is an unusual occurrence in patients
with hypertrophic cardiomyopathy. To determine the
incidenceand possiblepathophysiologic mechanismsreo
sponsible for this process, the serial clinical and labo-
ratory data of 62 patients with the diagnosis of hyper-
trophic cardiomyopathy were analyzed. During a mean
follow-up period of 8 years (range 2 to 21), 5 patients
(Group A)developed leftventricularhypokinesia, whereas
the remaining 57 patients (Group B)continued to exhibit
the clinical and laboratory findingsof hypertrophic car-
diomyopathy.
Three patients developed a dilated left ventricle with
generalized hypokinesia; two other patients had seg-
mental left ventricular wall motion abnormalities. None
of these five patients who developed left ventricular
hypokinesiahad fixed coronary artery disease.The mean
Hypertrophic cardiomyopathy has been reported to progress
occasionally into a dilated hypokinetic left ventricle (1-5).
This process can occur acutely or chronically and can be
associated with a significant deterioration in clinical status.
Although the pathophysiology of this process is not fully
understood, some cases have been reported after a myo-
cardial infarction (1,3,5) or surgical septal myotomy and
myomectomy (2).
In an attempt to elucidate the pathophysiologic mecha-
nisms responsible for this process, 62 consecutive patients
with hypertrophic cardiomyopathy were followed up for a
mean period of 8 years (range 2 to 21) to determine the
incidence and possible predictors of development of left
ventricular hypokinesia.
From the Division of Cardiology, St. Luke's Episcopal Hospital and
the Texas Heart Institute, Houston, Texas.
Manuscript received May 13, 1986; revised manuscript received August
20. 1986. accepted September 5, 1986.
Address for reprints: Sayid Fighali, MD, 51. Luke's Episcopal Hospital.
PO Box 20269. Houston, Texas 77225.
© 1987 by the American College of Cardiology
age, sex, mean duration of follow-up, presence of coro-
nary myocardial bridges and angina pectoris, and an
interventricular gradient were all similar in Groups A
and B. Midventricular obliteration was seen in 4 (80%)
of the 5 patients in Group A and in 4 (7%) of the 57
patients in Group B (p < 0.001).
Findings from this study reveal that segmental or
generalized left ventricular hypokinesia can develop in
patients with hypertrophic cardiomyopathy in the ab-
senceof fixed coronary artery disease. Such hypokinesia
can occur after an acute myocardial infarction or it can
develop gradually without clinical or electrocardio-
graphic evidence of infarction. Patients with the mid-
ventricular obliteration variant of hypertrophic cardio-
myopathy are at a higher risk of developing segmental
or diffuse left ventricular hypokinesia.
(J Am Coil CardioI1987;9:288-94)
Methods
Study patients. The medical records of 62 patients with
hypertrophic cardiomyopathy followed up by one group of
cardiologists were reviewed. In some patients the diagnosis
of hypertrophic cardiomyopathy was made before referral
to this center. The diagnosis was suspected on the basis of
clinical and electrocardiographic findings and was confirmed
by the presence of typical echocardiographic or angio-
graphic findings, or both. The echocardiographic criteria
included: I) asymmetric septal hypertrophy; 2) small left
ventricular cavity; 3) reduced septal systolic motion; and 4)
in the presence of left interventricular obstruction, systolic
anterior motion of the anterior mitral leaflet and early sys-
tolic closure of the aortic valve. The angiographic criteria
included I) a hypertrophic hypercontractile left ventricle
with systolic obliteration of different parts of the left ven-
tricle. and 2) in the obstructive form, the presence of a
dynamic intraventricular gradient.
All patients underwent cardiac catheterization and, when
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available, M-mode echocardiography during their initial as-
sessment. Patients were seen at least on a yearly basis. A
chest roentgenogram, electrocardiogram and M-modeecho-
cardiogram were obtained during the follow-up visit. Se-
lective coronary angiograms were available in 60 patients.
All patients had a left ventricular angiogram.
Laboratory methods. All laboratory results were re-
viewed by the authors. Left ventricular hypertrophy was
assessed electrocardiographically by the scoring criteria of
Romhilt and Estes (6). Q waves wereconsideredsignificant
if their duration was 0.04 second or more. The M-mode
echocardiographic techniques have been described previ-
ously (7) .
Hemodynamic measurements obtained during cardiac
catheterization included left ventricular end-diastolic pres-
sure, pulmonary capillary wedge pressure, left intraventric-
ular pressure gradient, at rest and after provocative maneu-
vers (after prematureventricularcontractions, after the Val-
salva maneuver and after the administration of sublingual
nitroglycerin) . Catheter entrapment was averted by using
end hole catheters only and by injecting contrast medium
to ensure a free position of the catheter tip within the left
ventricular cavity. Left ventricular volumes and ejection
fractions were calculated using the technique of Dodge (8).
The diagnosis ofmidcavity obstruction was made on the
basis oftypical angiographicfeatures: hourglassappearance
of the left ventricle with midventricular obliteration and an
apical chamber that was variable in size and contractility
(9). Many of these cases were associated with a pressure
gradient at the midventricular level. Selective coronary an-
giograms were obtained in multiple views.
Follow-up. In patients who exhibited progression to left
ventricularhypokinesia, the clinical course was divided into
two phases. The hypertrophic phase (phase I) began with
the initial cardiac assessment of the patient and covered the
time interval during which the disease behaved according
to physical and laboratory findings as a hypertrophic car-
diomyopathy. The hypokinetic phase (phase II) began with
the firstdetectionof clinicalor laboratory evidence. or both,
of left ventricularsegmental or generalized hypokinesia and
extended until the last clinical follow-up.
Statistical analysis. For frequency of occurrence vari-
ables, a chi-square analysis was performed to determine
statistical differences. For continuous variables, the Stu-
dent's t test for paired data was used.
Results
The 62 patients with hypertrophic cardiomyopathy were
followed up for a mean total period of 8 years (range 2 to
21). During this follow-up period, five patients developed
generalized or segmentalleft ventricularhypokinesia(Group
A). The remaining 57 patients (Group B) continued to ex-
hibit clinical and laboratory findings of hypertrophic car-
diomyopathy.
Serial Clinical and Laboratory Findings in Group A
Clinical findings (Table I). The mean total duration of
follow-up in Group A was II years (range 4 to 20). In
Patients I, 2 and 4, the progression to left ventricular hypo-
kinesia was associated with a gradual development of
congestive heart failure with deterioration in clinical status
over a period of several years. Patient I had undergone
septal myotomy and myomectomy 12 years before the first
documentation of left ventricular hypokinesia and had had
systemic hypertension for several years, treated with pro-
pranolol. Patient3 had rapiddeterioration in symptomsafter
sustaining an acute anteroseptal myocardial infarctioncom-
plicated by congestive heart failure. Patient 5 underwent
left ventricular myotomy and myomectomy I year after
detection of a left ventricular apical aneurysm.
Laboratory findings (Table 2). Electrocardiographic
findings. Left ventricular hypertrophy with or without an
associated strain pattern was initially present in all five pa-
tients. With the progression to phase II, Patients I and 2
lost the voltage criteria for left ventricular hypertrophy.
Patient 3 developed new deep Q waves in leads VI to V4
when he sustained an acute anteroseptal myocardial infarc-
tion.
Echocardiographic findings . The M-mode echocardio-
gram, when available in the hypertrophic phase. (phase I),
Table 1. Serial Clinical Findings in Five Patients (Group A) With Left Ventricular Hypokinesia
Patient I Patient 2 Patient 3 Patient 4 Patient 5
II II II II II
Sex F F M M F
Follow-up (yr) 20 17 4 11 4
Age (yr) 47 62 17 30 58 61 31 39 33 36
NYHA class II III II III II IV I III III III
Angina Yes No No No Yes No No No No No
I = hypertrophic phase; II = hypokinetic phase; NYHA = New York Heart Association.
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Table 2. Serial Laboratory Findings in Five Patients (Group A) With Left Ventricular Hypokinesia
Patient I Patient 2 Patient 3 Patient 4 Patient 5
II II II II II
Electrocardiographic Findings
Q wave + + + + + + + +
I,L I,L L A,L L L
Echocardiographic Findings
IVS t.7 0.8 0.9 1.9 1.3 2.0 1.I 1.8 1.8
PLVW 1.6 1.0 0.9 1.1 1.0 1.3 1.0 1.5 1.1
LVDS 2.0 3.8 4.0 t.7 3.6 2.0 4.2 1.8 2.0
LVDD 4.6 5.8 6.0 4.0 5.8 4.2 6.1 4.1 4.8
SAM Yes Yes No Yes Yes No No No No
ESC No No No Yes No No No Yes No
Angiographic and Hemodynamic Findings
MCO + + + + + +
LVWM Hyperc Dif Hyperc Dif Hyperc Ant hypok Hyperc Dif Hyperc Ap
hypok hypok ap dysk hypok dysk
LVEF(%) 75 35 70 45 75 45 70 30 75 60
IVG (mm Hg)
Rest 105 0 80 0 100 20 0 0 120 80
Prov 120 0 120 0 140 50 0 0
Level ? LVOT MV LVOT MV MV
and
LVOT
Coronary N N N N MB-LAD MB-LAD N N
arteries
I = hypertrophic phase; II = hypokinetic phase; + = present; - = absent. A = anterior; Ap = apical; Dif = diffuse; Dysk = dyskinesia;
ESC = early systolic closure of the aortic valve; Hyperc = hypercontractile; Hypok = hypokinesia; I = inferior; IVG = intraventricular gradient;
IVS = interventricular septum; L = lateral; LAD = left anterior descending coronary artery; Level = left ventricular level; LVDD = left ventricular
end-diastolicdimension; LVDS = left ventricularend-systolicdimension; LVEF = left ventricularejection fraction; LVH = left ventricularhypertrophy;
LVOT = left ventricular outflow tract; LVWM = left ventricular wall motion; MB = myocardial bridge; MCO = midcavity obliteration; MV =
midventricle: N = normal; Prov = provocative; PLVW = posterior left ventricular wall; SAM = systolic anterior motion of the anterior mitral leaflet.
showed a hypertrophic hypercontractile left ventricle in all
patients, with asymmetric septal hypertrophy in Patients 3
and 4. During the hypokinetic phase (phase II), left ven-
tricular diastolic dimension was above the normal range in
four patients. Sequential M-mode echocardiograms obtained
during the hypokinetic phase showed progressive increase
in left ventricular dimensions in Patients I, 2 and 4 and no
significant changes in Patients 3 and 5.
Hemodynamic and angiographic findings. Hemody-
namic studies performed during the hypertrophic phase (phase
I) revealed a significant intraventricular gradient in four
patients, all of whom had angiographic evidence of mid-
cavity obliteration. The level of obstruction was variable.
During phase II, only two patients had an intraventricular
gradient that was markedly reduced when compared with
that of phase I.
Initially, left ventricular angiograms revealed a hyper-
contractile left ventricle in all five patients. Left ventricular
wall motion abnormalities seen during phase II were global
in three patients and segmental in two (Fig. I and 2). None
of the patients had fixed coronary artery lesions on angi-
ography. Patient 3 was studied 3 days after he sustained an
acute myocardial infarction and was found to have normal
coronary arteries.
Comparison of Findings Between Groups A and B
(Table 3)
Clinical and laboratory findings obtained during the ini-
tial assessment of patients were compared between Groups
A (segmental or generalized hypokinesia) and B (hyper-
trophic cardiomyopathy). Mean age, sex, history of angina,
incidence of prior septal myotomy and myomectomy, pres-
ence of fixed coronary artery disease or myocardial bridges,
presence of an intraventricular pressure gradient and dura-
tion of symptoms were all similar in Groups A and B, as
was the mean duration of follow-up. On the other hand, the
presence of midcavity obliteration was statistically more
common in Group A (p < 0.001). In addition, patients with
obstructive hypertrophic cardiomyopathy in Group A had a
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A B
Figure l. Patient 4. Left ventricular end-diastolic (upper) and
end-systolic (lower) angiographic frames during phase I (hyper-
trophy) (A) and phase II (hyperkinesia) (B).
higher mean rest intraventricular gradient compared with
that of patients in Group B (p < 0.05).
Discussion
Incidence of ventricular hypokinesia. The develop-
ment of segmental or generalized left ventricular hypoki-
nesia with or without left ventricular dilation is an unusual
occurrence in patients with hypertrophic cardiomyopathy,
Adelman et al. (10), in a series of 60 patients with hyper-
trophic cardiomyopathy, reported a 7% incidence rate of
congestive heart failure. Ten Cate and Roelandt (2) followed
up 50 patients with hypertrophic cardiomyopathy for a mean
interval of 4 years. Two patients (4%) developed a dilated
poorly contracting left ventricle. In our study of 62 patients
followed up for a mean period of 8 years, five patients (8%)
(Group A) developed segmental or generalized left ventric-
ular hypokinesia.
Pathophysiologic mechanisms. A small number of pa-
tients with hypertrophic cardiomyopathy can develop seg-
mental or diffuse left ventricular hypokinesia (our Group
A). This process can follow an acute myocardial infarction
(3,5) or it can occur silently without any clinical or electro-
cardiographic evidence of myocardial infarction (1,2,1 I).
Although the pathophysiologic mechanisms leading to left
ventricular wall motion abnormalities can be different in
these two clinical situations, the pathologic findings are
similar, that is, transmural myocardial infarction and scar-
ring, which can be diffuse or localized to one area of the
left ventricle ( I I). The etiology of the myocardial infarction
is still unclear. Morphologic and angiographic studies show
normal extramural coronary arteries in the majority of these
cases (I ,2,11,12). In our study, none of the five patients in
Group A had fixed coronary artery disease. Some of the
mechanisms thought to be involved in the causation of the
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myocardial infarction in these cases include: I) embolization
to a major coronary artery branch. 2) coronary artery spasm,
3) myocardial bridging, 4) oxygen supply/demand mis-
match. 5) small vessel coronary artery disease, and 6) prior
septal myotomy or myomectomy.
In the absence of any documented cases. the role of
coronary embolization or coronary artery spasm in the cau-
sation of myocardial infarction in patients with hypertrophic
cardiomyopathy is purely theoretical.
B
Figure 2. Patient 3. A. Left ventricular end-diastolic (upper) and
end-systolic (lower) angiographic frames during phase I (hyper-
trophy). B. Fourdays after development of an acute anteroseptal
myocardial infarction.
Table 3. Comparison of Clinical and Laboratory Findings in Groups A and B
Group A Group B
(with hypokinesia) (without hypokinesia)
No. 'Ye No. Ile
Patients 5 X 57 92
Men 2 40 32 56
Mean age (yr) 37 34
Angina (no.) 2 40 32 56
Follow-up (mean) (yr) 11 X
CAD 0 0 12 21
Myocardial bridging I 20 I) 16
Previous I 20 10 17
myotomy/myomectomy
IYG 4 gO 42 74*
MYO 4 gO 4 7t
Mean IYG (0101 Hg) 101 63
* = p < 0.05: t = P < 0.001. CAD = coronary artery disease: lYG = intraventricular pressure gradient:
MYO = midventricular obliteration.
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Figure 3. Diagrams of midventricular obliteration with midven-
tricular obstruction, before (A) and after (8) the development of
a leftventricularapicalaneurysm. 1 = lowerpressure; 2 = higher
pressure; 3 = compensatory apical hypertrophy.
A/though the incidence of myocardial bridging (/3) is
higher in patients with hypertrophic cardiomyopathy than
in the general population, the role of this finding in the
causation of angina or infarction, or both, remains unclear .
In our study. the incidence of myocardial bridges was similar
in patients who developed left ventricular hypokinesia and
those who did not. Some studies (11) have reported that
sections of fibrotic myocardium from patients with hyper-
trophic cardiomyopathy have shown wall thickening with
luminal narrowing in the intramural small coronary arteries.
It is not known. however, whether this is the cause or the
consequence of myocardial fibrosis.
Septal myomectomy can be complicated by septa/ in-
farction if it is associated with interruption of the blood
supply to the septum. In our study. the only patient in Group
A who had prior septal myomectomy had undergone surgery
12 years before the detection of left ventricular hypokinesia.
Oxygen supply/demand mismatch due to excessive mvo-
cardia/ thickness has been reported for years to be a possible
mechanism leading to myocardial scarring. Positron emis-
sion tomographic studies ( 14) performed on some patients
with hypertrophic cardiomyopathy have shown reduction in
blood flow and free fatty acid uptake in the septum as com-
pared with the left ventricular free wall. Other studies (15)
suggest that decreased subendocardial blood flow resulting
in subendocardial ischemia can occur frequently in patients
with hypertrophic cardiomyopathy, even in the absence of
angina.
Role of mid ventricular obliteration. It has already been
shown (16) that marked variation in the distribution of left
ventricular hypertrophy occurs in patients with hypertrophic
cardiomyopathy. Midventricular obstruction is an uncom-
mon variant of hypertrophic cardiomyopathy in which the
hypertrophic process predominates at the midventricular level
tract. resulting in some cases in a high pressure apical cham-
ber (9 , 17,18,19). Gordon et al. (20) reported midventricular
obstruction in three who had an associated apical aneurysm.
In these three cases it was not known whether the midven-
tricular obstruction was the consequence of apical infarction
in patients with hypertrophic cardiomyopathy and cavity
obliteration or whether it was the cause of apical infarction
and apical aneurysm formation (21) . In our study, we es-
tablished that patients with hypertrophic cardiomyopathy
and midventricular obstruction can develop an apical an-
eurysm or more generalized left ventricular wall motion
abnormalities .
Mechanisms . Although we are uncertain why midcavity
obliteration leads to left ventricular hypokinesia in these
patients. we are suggesting two mechanisms. Midcavity
obliteration in this study was associated with a large pressure
gradient across the midventricular level in many patients.
This obstruction to flow during systole might lead to further
compensatory apical hypertrophy, which by itself could make
midventricular obstruction more severe. A stage is reached
where the pressure overload in the apical chamber leads to
myocardial dysfunction with dilation of the apical chamber
(Fig. 3). Another mechanism that can be involved in this
situation is related to the sequence of myocardial fiber short-
ening during systole. Although the left ventricle in hyper-
trophic cardiomyopathy is hypercontractile, the effective
shortening of the total left ventricular axis (junction of aorta
and left ventricle to epicardial apex) is reduced (15). The
hypercontractile septum is thought to splint the long axis of
the left ventricle. preventing apical retraction. This inability
to elevate the apex toward the base can be more exaggerated
in the presence of midcavity obliteration. resulting gradually
in apical dyskinesia and dilation of the apical chamber. It
is unclear if development of generalized hypokinesia is re-
lated to formation of an apical aneurysm in these patients.
Conclusions. Hypertrophic cardiomyopathy can occa-
sionally progress to segmental or generalized left ventricular
hypokinesia. In this series of 62 patients. the rate of this
progression was close to 1%/patient per year. This pro-
gression can follow an acute myocardial infarction or it can
develop gradually without clinical or electrocardiographic
evidence of infarction. The incidence of coronary artery
disease. coronary myocardial bridging. left intraventricular
dynamic obstruction and previous septal myotomy-
myomectomy was similar in patients who developed left
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ventricular hypokinesia and in those who did not. Patients
with the midventricular obliteration variant of hypertrophic
cardiomyopathy are at a higher risk of developing left ven-
tricular hypokinesia.
We thank Roberto Lufschanowski, MD, Paulo Angelini. MD and Richard
Leachman, MD for allowing us to include their patients in this study. and
also for their valuable comments.
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